![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Retreatment of Hepatitis C Infection in Patients Who Failed Glecaprevir/Pibrentasvir
|
|
|
Reported by Jules Levin
CROI 2018 March 4-7 Boston MA
David Wyles,1 Ola Weiland,2 Betty Yao,3 Frank Weilert,4 Stuart Gordon,5 Fred Poordad,6 Albrecht Stoehr,7 Ashley St. John Mark Brown,8 Stefan Mauss,9 Suvajit Samanta,3 Tami Pilot-Matias,3 Lino Rodrigues Jr.,3 Roger Trinh3
1Denver Health Medical Center, Denver, Colorado, USA; 2Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden; 3AbbVie Inc., North Chicago, Illinois, USA; 4Waikato Hospital, Hamilton, New Zealand; 5Henry Ford Hospital, Detroit, Michigan, USA; 6Texas Liver Institute, UT Health, San Antonio, Texas, USA; 7IFI Studien und Projekte Gmbh, Hamburg, Germany; 8Imperial College Healthcare NHS Trust, London, United Kingdom; 9Center for HIV and Hepatogastroenterology, Dusseldorf, Germany
![0309181](../images%20/030918/030918-1/0309181.gif)
![0309182](../images%20/030918/030918-1/0309182.gif)
![0309183](../images%20/030918/030918-1/0309183.gif)
![0309184](../images%20/030918/030918-1/0309184.gif)
![0309185](../images%20/030918/030918-1/0309185.gif)
![0309186](../images%20/030918/030918-1/0309186.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|